Mxi1-Srα: a novel Mxi1 isoform with enhanced transcriptional repression potential

Mxi1 belongs to the Myc/Max/Mad network of proteins that have been implicated in the control of multiple aspects of cellular behavior. Previously, we had reported that the mouse mxi1 gene gives rise to two distinct transcript forms that can encode proteins with dramatically different functional abil...

Full description

Saved in:
Bibliographic Details
Published inOncogene Vol. 23; no. 55; pp. 8887 - 8899
Main Authors DUGAST-DARZACQ, Claire, PIRITY, Melinda, BLANCK, Jennifer K, SCHERL, Alexis, SCHREIBER-AGUS, Nicole
Format Journal Article
LanguageEnglish
Published Basingstoke Nature Publishing 25.11.2004
Nature Publishing Group
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:Mxi1 belongs to the Myc/Max/Mad network of proteins that have been implicated in the control of multiple aspects of cellular behavior. Previously, we had reported that the mouse mxi1 gene gives rise to two distinct transcript forms that can encode proteins with dramatically different functional abilities. The Mxi1-SR protein (here termed Mxi1-SRβ) can interact with Sin3/histone deacetylase and function as a potent transcriptional repressor and growth suppressor, while the Mxi1-WR protein lacks these activities. Here, we describe a new mxi1-derived transcript form (termed mxi1-SRα) whose expression is governed by its own promoter, resulting in a spatiotemporally distinct expression profile from that of the highly related mxi1-SRβ form. Moreover, the Mxi1-SRα protein product, with its unique Sin3 interacting domain, has a greater affinity than its Mxi1-SRβ counterpart for the Sin3 adapter proteins as well as an enhanced potential for transcriptional repression in transient reporter assays. Our identification of this novel Mxi1 isoform that results from alternative 5′ exon usage adds an additional layer of complexity to the Mad/Mxi1 family. In addition, our findings warrant re-evaluation of mxi1 expression patterns on the cellular level and its status in human cancer samples, with a renewed focus on the distinct isoforms.
Bibliography:ObjectType-Article-2
SourceType-Scholarly Journals-1
ObjectType-Feature-1
content type line 23
ISSN:0950-9232
1476-5594
DOI:10.1038/sj.onc.1208107